ARTV - Artiva Biotherapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$37.50
DETAILS
HIGH:
$40.00
LOW:
$35.00
MEDIAN:
$37.50
CONSENSUS:
$37.50
UPSIDE:
400.67%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue | 0 | 0.3 | 33.5 | 4.9 | 2.0 | 0 |
| Cost of Revenue | 2.6 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (2.6) | 0.3 | 33.5 | 4.9 | 2.0 | 0 |
| Operating Expenses | ||||||
| R&D Expenses | 69.5 | 50.3 | 50.3 | 44.0 | 42.4 | 13.8 |
| SG&A Expenses | 20.3 | 17.2 | 13.9 | 20.8 | 12.9 | 4.4 |
| Other Expenses | (1.8) | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 88.0 | 67.5 | 64.2 | 64.8 | 55.3 | 18.3 |
| Operating Income | ||||||
| Operating Income | (90.6) | (67.3) | (30.7) | (59.8) | (53.3) | (18.3) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0.2 |
| Interest Income | 6.0 | 5.3 | 2.5 | 1.3 | 0 | 0.0 |
| Profitability | ||||||
| EBITDA | (81.3) | (56.1) | (25.4) | (57.2) | (71.6) | (17.5) |
| EBIT | (83.9) | (58.5) | (27.6) | (58.3) | (71.8) | (17.6) |
| Income Before Tax | (83.9) | (58.5) | (27.6) | (58.3) | (71.8) | (18.0) |
| Income Tax Expense | 0 | 0 | 0.1 | 0.1 | 0 | 0 |
| Net Income | (83.9) | (58.5) | (27.7) | (58.4) | (71.8) | (18.0) |
| Per Share Data | ||||||
| EPS (Basic) | -3.43 | -5.20 | -1.19 | -3.32 | -4.08 | -1.02 |
| EPS (Diluted) | -3.43 | -5.20 | -1.19 | -3.32 | -4.08 | -1.02 |
| Shares Outstanding | 24.4 | 24.4 | 23.3 | 17.6 | 17.6 | 17.6 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 26.7 | 40.2 | 53.5 | 102.5 | 160.9 | 25.4 | 1.9 |
| Short-Term Investments | 81.3 | 145.2 | 23.5 | 0 | 0 | 0 | 0 |
| Net Receivables | 0.8 | 0.1 | 1.8 | 0.5 | 0.5 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 3.9 | 3.1 | 1.1 | 1.6 | 0 | 0 | 0 |
| Total Current Assets | 112.7 | 188.6 | 79.8 | 104.7 | 162.3 | 26.1 | 2.0 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 17.4 | 20.4 | 24.6 | 27.6 | 4.1 | 2.4 | 2.5 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0.2 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.9 | 0.5 | 0.7 | 0.5 | 3.6 | 0.7 | 0.4 |
| Total Non-Current Assets | 18.3 | 20.9 | 25.3 | 28.4 | 7.6 | 3.1 | 2.9 |
| Total Assets | 130.9 | 209.6 | 105.1 | 133.1 | 169.9 | 29.2 | 4.8 |
| Current Liabilities | |||||||
| Account Payables | 0.4 | 1.1 | 0.6 | 1.1 | 1.4 | 2.2 | 0.3 |
| Short-Term Debt | 3.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 10.9 | 7.3 | 0 | 0 |
| Other Current Liabilities | 2.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 13.1 | 12.3 | 12.2 | 25.6 | 19.3 | 5.8 | 0.9 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 7.9 | 0 | 0 | 0 | 0 | 0 | 5.6 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 216.4 | 216.4 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0.1 | 241.6 | 0.1 | 0.1 | 43.4 | 0.2 |
| Total Non-Current Liabilities | 7.9 | 10.7 | 254.9 | 248.1 | 239.5 | 45.0 | 7.9 |
| Total Liabilities | 21.0 | 22.9 | 267.1 | 273.8 | 258.8 | 50.8 | 8.8 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (330.5) | (246.7) | (181.3) | (152.6) | (93.8) | (22.0) | (4.0) |
| Accumulated Other Comprehensive Income | 0.1 | (0.1) | 0.3 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 110.0 | 186.6 | (162.0) | (140.7) | (88.9) | (21.6) | (4.0) |
| Total Liabilities & Equity | 130.9 | 209.6 | 105.1 | 133.1 | 169.9 | 29.2 | 4.8 |
| Debt Metrics | |||||||
| Total Debt | 10.9 | 14.4 | 16.9 | 19.4 | 1.7 | 2.1 | 7.8 |
| Net Debt | (15.8) | (25.9) | (36.6) | (83.1) | (159.2) | (23.3) | 5.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | (83.9) | (65.4) | (28.7) | (58.8) | (71.8) | (18.0) |
| Depreciation & Amortization | 2.6 | 2.4 | 2.3 | 1.2 | 0.2 | 0.1 |
| Stock-Based Compensation | 6.8 | 7.0 | 7.1 | 6.6 | 4.3 | 0.3 |
| Change in Working Capital | (0.4) | (0.3) | (28.3) | (3.9) | 33.4 | 4.4 |
| Other Non-Cash Items | (1.9) | 1.3 | 0.3 | 4.1 | 18.6 | (0.3) |
| Operating Cash Flow | (76.8) | (55.0) | (47.4) | (50.8) | (15.3) | (13.5) |
| Investing Activities | ||||||
| Capital Expenditure | (2.6) | (0.6) | (3.3) | (6.3) | (1.7) | (0.3) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (44.9) | (176.2) | (49.5) | 0 | 0 | 0 |
| Sales/Maturities of Investments | 110.9 | 56.4 | 26.8 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 63.4 | (120.5) | (26.0) | (6.3) | (1.7) | (0.3) |
| Financing Activities | ||||||
| Net Debt Issuance | (0.1) | (0.1) | 0 | 0 | 0 | 3 |
| Stock Repurchased | 0 | (4.2) | (0.0) | (0.0) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.2) | 0.1 | 24.4 | (1.3) | (1.9) | (0.5) |
| Financing Cash Flow | 0.0 | 162.2 | 24.4 | (1.3) | 152.8 | 37.4 |
| Cash Position | ||||||
| Net Change in Cash | (13.3) | (13.3) | (49.0) | (58.4) | 135.7 | 23.6 |
| Cash at Beginning | 40.5 | 53.8 | 102.8 | 161.2 | 25.4 | 1.9 |
| Cash at End | 27.2 | 40.5 | 53.8 | 102.8 | 161.2 | 25.4 |
| Free Cash Flow | (79.3) | (55.7) | (50.7) | (57.1) | (17.0) | (13.8) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 0 | 0.3 | 33.5 | 4.9 | 2.0 | 0 | |
| Gross Profit | (2.6) | 0.3 | 33.5 | 4.9 | 2.0 | 0 | |
| Operating Income | (90.6) | (67.3) | (30.7) | (59.8) | (53.3) | (18.3) | |
| Net Income | (83.9) | (58.5) | (27.7) | (58.4) | (71.8) | (18.0) | |
| EPS (Diluted) | -3.43 | -5.20 | -1.19 | -3.32 | -4.08 | -1.02 | |
| Balance Sheet | |||||||
| Cash & Equivalents | 26.7 | 40.2 | 53.5 | 102.5 | 160.9 | 25.4 | 1.9 |
| Total Assets | 130.9 | 209.6 | 105.1 | 133.1 | 169.9 | 29.2 | 4.8 |
| Total Debt | 10.9 | 14.4 | 16.9 | 19.4 | 1.7 | 2.1 | 7.8 |
| Stockholders' Equity | 110.0 | 186.6 | (162.0) | (140.7) | (88.9) | (21.6) | (4.0) |
| Cash Flow | |||||||
| Operating Cash Flow | (76.8) | (55.0) | (47.4) | (50.8) | (15.3) | (13.5) | |
| Capital Expenditure | (2.6) | (0.6) | (3.3) | (6.3) | (1.7) | (0.3) | |
| Free Cash Flow | (79.3) | (55.7) | (50.7) | (57.1) | (17.0) | (13.8) | |